High-dose therapy followed by stem cell transplantation in Hodgkin's lymphoma: past and future.
about
Advancement in high dose therapy and autologous stem cell rescue in lymphomaBrentuximab vedotin in the treatment of a patient with refractory Hodgkin disease and Proteus syndrome - a case report and discussionIL-17 induces radiation resistance of B lymphoma cells by suppressing p53 expression and thereby inhibiting irradiation-triggered apoptosis.Role of Consolidative Radiation Therapy After Autologous Hematopoietic Cell Transplantation for the Treatment of Relapsed or Refractory Hodgkin Lymphoma.A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience.Novel regimens prior to autologous stem cell transplantation for the management of adults with relapsed/refractory non-Hodgkin lymphoma and Hodgkin lymphoma: alternatives to BEAM conditioning.
P2860
High-dose therapy followed by stem cell transplantation in Hodgkin's lymphoma: past and future.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
High-dose therapy followed by ...... n's lymphoma: past and future.
@en
type
label
High-dose therapy followed by ...... n's lymphoma: past and future.
@en
prefLabel
High-dose therapy followed by ...... n's lymphoma: past and future.
@en
P2093
P2860
P1476
High-dose therapy followed by ...... n's lymphoma: past and future.
@en
P2093
Alessandro Isidori
Barbara Guiducci
Federica Loscocco
Giuseppe Visani
Paola Picardi
Pier Paolo Piccaluga
Sara Barulli
Teresa Ricciardi
P2860
P304
P356
10.1586/17474086.2013.814451
P577
2013-08-01T00:00:00Z